# Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

> **NCT02049320** · — · COMPLETED · sponsor: **Joseph D. Tobias** · enrollment: 38 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT02049320
- **Lead sponsor:** Joseph D. Tobias
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049320, "Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02049320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*